Who We Are

RadioMedix, Inc. is a clinical-stage biotechnology company, based in Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. 

We commercialize  radiopharmaceuticals for PET imaging and targeted alpha and beta-emitter therapy.

What We Do

Our operations cover the entire value chain from drug discovery to sponsoring and conducting clinical trials to scale up manufacturing. RadioMedix is compliant with 21 CFR Parts 210,211,212.

Our Molecular Core Facility supports the synthesis, and the pre-clinical evaluation of our drugs and contract projects. Our cGMP Suite manufactures doses for  Phase I-III clinical trials. Our state of the art commercial manufacturing site is prepared for scaled up and commercial grade production of radiolabeled drugs and isotopes (The Spica Center).

Our Mission

To improve patients life by providing innovative radiotheranostics and accelerating of discoveries in nuclear medicine.

Meet Our Management Team

At RadioMedix, Inc., our leadership team is dedicated to pioneering advancements in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and therapy. Based in Texas, our clinical-stage biotechnology company thrives on innovation and excellence. Our team brings together a wealth of experience and expertise in the fields of radiopharmaceuticals, PET imaging, and targeted alpha and beta-emitter therapy.

Career Opportunities

At RadioMedix, Inc., we are at the forefront of innovation in targeted radiopharmaceuticals for cancer diagnosis, monitoring, and therapy. Our team is passionate about making a difference in the lives of patients through cutting-edge science and technology. We are always looking for talented and dedicated individuals to join our mission-driven team.